12 results match your criteria: "Hospital San Antonio de Padua[Affiliation]"
Assessment of TISA "Transcutaneous Implant Skin Anomalies" scale for cutaneous complications related to bone conduction hearing implants.
Am J Otolaryngol
December 2024
Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia. Electronic address:
Objective: To describe the use of the TISA (Transcutaneous Implant Skin Anomalies) scale by members of the Colombian Association of Otology (ACON) in the evaluation of patients using bone conduction implants.
Methods: A cross-sectional descriptive observational study was conducted among the members of the Colombian Association of Otology. A voluntary survey was performed, where participants evaluated images of patients with transcutaneous bone conduction implants exhibiting different skin conditions.
TNFα-inhibitors cycling with golimumab as second drug in inflammatory arthritis patients: Data from the multicenter GO-REAL registry.
Reumatol Clin (Engl Ed)
December 2024
Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina. Electronic address:
Article Synopsis
- This study evaluated the effectiveness and persistence of golimumab (GLM) in patients with rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis who previously used other TNF inhibitors compared to those who haven't.
- A total of 192 patients were included, with follow-up results indicating that the majority discontinued GLM due to inefficacy, and the median survival for GLM treatment was similar for both experienced and naive patients.
- The study concluded that prior TNFi experience did not significantly affect the survival or persistence of GLM treatment, but having public health insurance was linked to higher discontinuation rates.
Prevalence and incidence of uveitis in patients with spondyloarthritis: the impact of the biologics era. Data from International ASAS-COMOSPA Study.
Rheumatology (Oxford)
October 2024
Department of Rheumatology, University of Ghent, Ghent, Belgium.
Article Synopsis
- Uveitis is a common complication in patients with Spondyloarthritis (SpA), and this study examined how frequently it occurs, its geographical variations, and whether it has changed since the introduction of biologic treatments.
- A total of 3984 patients across 22 countries were assessed, revealing that the likelihood of experiencing uveitis increases significantly over time, with various factors like HLA-B27 positivity and a family history of uveitis linked to a higher risk.
- Results indicated a drastic reduction in the prevalence and incidence of uveitis in patients who started treatment after 2000, suggesting that biologic therapies may help mitigate this condition.
Article Synopsis
- This study conducts the first large-scale genetic analysis of inherited eye diseases in Argentina, involving a retrospective analysis of medical records from 22 ophthalmology and genetics services across 13 provinces, including 773 patients primarily with inherited retinal diseases.* -
- The most prevalent condition identified was retinitis pigmentosa (RP), comprising 62% of cases, with the most commonly affected genes being USH2A, RPGR, and ABCA4, which are linked to various types of retinal dystrophies.* -
- Notably, the research uncovered 35% of previously unreported pathogenic variants, highlighting the genetic diversity in inherited eye diseases in Argentina and establishing a foundational reference for future studies and clinical applications.*
Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
Clin Rheumatol
February 2023
Unidad de Investigación de la Sociedad Argentina de Reumatología, Buenos Aires, Argentina.
Background/objective: This study aims to describe the course and to identify poor prognostic factors of SARS-CoV-2 infection in patients with rheumatic diseases.
Methods: Patients ≥ 18 years of age, with a rheumatic disease, who had confirmed SARS-CoV-2 infection were consecutively included by major rheumatology centers from Argentina, in the national, observational SAR-COVID registry between August 13, 2020 and July 31, 2021. Hospitalization, oxygen requirement, and death were considered poor COVID-19 outcomes.
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance.
Ann Rheum Dis
July 2022
Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Article Synopsis
- The study aimed to identify factors linked to severe outcomes in individuals with systemic lupus erythematosus (SLE) who contracted COVID-19, using data from a global registry.
- Significant findings revealed that older age, male sex, higher doses of prednisone, the presence of comorbidities (like kidney or cardiovascular disease), and moderate to high SLE disease activity were associated with more severe outcomes.
- Furthermore, the type of medication used affected the severity, with treatments like mycophenolate, rituximab, and cyclophosphamide correlated with worse outcomes compared to hydroxychloroquine, while methotrexate and belimumab showed more favorable results.
Depression Is a Major Determinant of Functional Capacity in Rheumatoid Arthritis.
J Clin Rheumatol
September 2021
From the Section of Rheumatology, Instituto de Rehabilitación Psicofísica, Ciudad Autónoma de Buenos Aires.
Objective: The aim of this study was to determine the prevalence of depression among rheumatoid arthritis (RA) Argentinean patients and its association with sociodemographic and clinical factors.
Methods: We performed a cross-sectional study of consecutive adults with RA. Sociodemographic data, comorbidities, RA disease activity, and current treatment were assessed.
A useful tool to assess quality of LIFE in rheumatoid arthritis patients that does not require a license: QOL-RA II.
Clin Rheumatol
November 2020
Section of Rheumatology, Instituto de Rehabilitación Psicofísica, Echeverría 955, 1429, Buenos Aires, Argentina.
To validate the Quality of Life-Rheumatoid Arthritis Scale II (QOL-RA II) in an Argentinean cohort of patients with rheumatoid arthritis (RA). Patients ≥ 18 years old, with a diagnosis of RA according to ACR-EULAR 2010 criteria, were included in a cross-sectional study. Sociodemographic data, comorbidities, RA characteristics, disease activity, and current treatment were registered.
View Article and Find Full Text PDFSpanish Validation of the GEPARD Questionnaire for the Detection of Psoriatic Arthritis in Argentinian Patients with Psoriasis.
Dermatology
June 2019
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Background/objective: Psoriatic arthritis (PsA) is preceded by psoriasis in approximately 80% of cases. Dermatologists are pivotal for early detection. It is important to have simple tools that allow the detection of PsA in patients with skin psoriasis.
View Article and Find Full Text PDFEvaluation of the Educational Needs in Argentine Patients with Rheumatoid Arthritis Using the SpENAT Questionnaire.
Reumatol Clin (Engl Ed)
September 2021
Hospital San Antonio de Padua, Río Cuarto, Córdoba, Argentina.
Background: The SpENAT, a Spanish version of the Educational Needs Assessment Tool, is a self-completed questionnaire that assesses educational needs (ENs) with the purpose of providing tailored and patient-centered information. It consists of 39 questions grouped into the 7 following domains: Pain management, Movement, Feelings, Arthritic process, Treatments, Self-help measures and Support system.
Objectives: The objective of the study was to describe the ENs of rheumatoid arthritis (RA) patients using the SpENAT and to determine the main sources of information consulted by these patients.
Secukinumab: a promising therapeutic option in spondyloarthritis.
Clin Rheumatol
September 2016
University of Buenos Aires, Buenos Aires, Argentina.
Psoriatic arthritis (PsA) is the second most common chronic inflammatory joint disease. Ankylosing spondylitis (AS) is another less common but equally chronic and disabling spondyloarthritis (SpA). Therapeutic agents for the treatment of these diseases have been somewhat lacking as compared with those available for rheumatoid arthritis, which represents a significant challenge for both the treating physician and the pharmaceutical industry.
View Article and Find Full Text PDF[Pulmonary alveolar proteinosis: report of two cases and review of the literature].
Rev Fac Cien Med Univ Nac Cordoba
September 2010
Servicios de Clínica Medica, Anatomía Patológica y Cirugía de tórax, Nuevo Hospital San Antonio de Padua, Rio Cuarto, Córdoba, Argentina.
Pulmonary alveolar proteinosis is a rare disease characterized by extensive radiological and tomographic pulmonary lesions and a variable clinical picture ranging from pulmonary insufficiency to spontaneous remission. Among its three described forms, the so called Idiopathic or Adult form is responsible for more than 80% of published cases. It's physiopathology depends on an autoimmune process directed against the GM-CSF (Granulocite Macrophage- Colony Stimulating Factor) that induces a functional defect of the macrophage with consequent intraalveolar accumulation of surfactant.
View Article and Find Full Text PDF